Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person BRCA1 C61G [nucleoplasm]

Class:Id	EntityWithAccessionedSequence:9700890
_displayName	BRCA1 C61G [nucleoplasm]
_timestamp	2020-09-21 14:33:47
compartment	[Compartment:7660] nucleoplasm
created	[InstanceEdit:9700888] Orlic-Milacic, Marija, 2020-09-21
disease	[Disease:1500689] cancer [Disease:9700885] hereditary breast ovarian cancer syndrome [Disease:1500576] breast cancer
endCoordinate	1863
hasModifiedResidue	[ReplacedResidue:9700889] L-cysteine 61 replaced with glycine
literatureReference	[LiteratureReference:5659818] Characterization of an Italian founder mutation in the RING-finger domain of BRCA1 [LiteratureReference:5659810] Identification of a RING protein that can interact in vivo with the BRCA1 gene product [LiteratureReference:9663191] Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination
name	BRCA1 C61G BRCA1 Cys61Gly
referenceEntity	[ReferenceGeneProduct:50950] UniProt:P38398 BRCA1 [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9700891] R-HSA-9700890.1
startCoordinate	1
(hasMember)	[CandidateSet:9663193] BRCA1 mutants (BARD1 binding) [nucleoplasm] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by BRCA1 C61G [nucleoplasm] (9700890)